Back to search

Article

BRAFV600E Mutation Drives Cisplatin Resistance in Colorectal Cancer by Attenuating Ferroptosis Through the NF-κB/Lipocalin 2 Signaling Pathway

2026-06-26

Abstract excerpt

<title>Abstract</title> <p> <bold>Purpose:</bold> Colorectal cancers (CRCs) harboring the BRAFV600E (V600E) mutation exhibit aggressive behavior and chemotherapy resistance, yet the underlying mechanisms remain poorly understood. Ferroptosis, which is driven by iron-dependent lipid peroxidation, has emerged as a promising process. This study aimed to determine whether BRAFV600E regulates cisplatin sensitivity b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e73ed13b-3e0b-5ce4-bd11-5b8d2f28c120
DOI
10.21203/rs.3.rs-10147889/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BRAFV600E Mutation Drives Cisplatin Resistance in Colorectal Cancer by Attenuating Ferroptosis Through the NF-κB/Lipocalin 2 Signaling PathwayDOI 10.21203/rs.3.rs-10147889/v1
Select a neighboring publication to make it the new centre.